Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Kristin Zimmerman Savill

David Geffen School of Medicine at UCLA

United States

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Immunology

10%

Targeted Therapy

20%

Stem Cell Transplantation

20%

Women's Health

10%

Cancer Research

10%

Cancer Therapy

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Development of a Novel Methodology for Endpoints Assessing Response to Lymphoma Treatment in Real-World Studies

Open Date:

Close Date:

Articles6

Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors

Article Link

Year:

2022

Lower-Risk Myelodysplastic Syndromes: Erythropoiesis-Stimulating Agent Treatment Approaches and Outcomes in the United States

Article Link

Year:

2021

Real-World Treatment of Patients with Large B-Cell Lymphoma in the United States with Chimeric Antigen Receptor T-Cell Therapy

Article Link

Year:

2021

PMS25 Patient-Reported Outcome Labeling for Rheumatoid Arthritis Drugs Approved in the United States: 2010-2019

Article Link

Year:

2021

Awareness and utilization of tumor mutation burden (TMB) as a biomarker for administration of immuno-oncology (I-O) therapeutics by practicing community oncologists in the United States (U.S.).

Article Link

Year:

2021

Racial disparity in uterine cancer treatment and survival: A matter of Black women’s lives.

Article Link

Year:

2021

How do I reach out?

Meet Kite AI